Tumor Lysis Syndrome

• FDA approval · 2015-05-13
  FDA Approved: ALOPRIM — Supplemental Application (Mylan Institutional LLC)

  The FDA approved a supplemental application for ALOPRIM (allopurinol) submitted by Mylan Institutional LLC, resulting in updated labeling.

• FDA approval · 2015-02-03
  FDA Approved: ELITEK — Supplemental Application (Sanofi-Aventis U.S. LLC)

  FDA approves a supplemental application for ELITEK (rasburicase) by Sanofi-Aventis U.S. LLC.

• FDA approval · 2009-10-16
  FDA Approved: ELITEK — Supplemental Application (Sanofi-Aventis U.S. LLC)

  FDA approved a supplemental application for ELITEK (rasburicase) submitted by Sanofi-Aventis U.S. LLC. The action confirms regulatory cleara…

• FDA approval · 2009-01-23
  FDA Approved: ALLOPURINOL — Supplemental Application (Actavis Pharma, Inc.)

  The FDA approved a supplemental application for allopurinol from Actavis Pharma, updating the existing NDA.

• FDA approval · 2007-09-10
  FDA Approved: ELITEK — Supplemental Application (Sanofi-Aventis U.S. LLC)

  FDA approved a supplemental application for ELITEK (rasburicase) submitted by Sanofi-Aventis U.S. LLC.

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.